Nakao Sanshiro, Nakaseko Chiaki, Ishii Takahiro, Terai Kensuke, Shimizu Naomi
Hematology, Toho University Medical Center Sakura Hospital, Sakura, JPN.
Hematology, International University of Health and Welfare School of Medicine, Narita, JPN.
Cureus. 2025 Jun 25;17(6):e86768. doi: 10.7759/cureus.86768. eCollection 2025 Jun.
Objective Vitamin B6 (VB6) deficiency leads to microcytic hypochromic anemia with ringed sideroblasts. Sideroblastic anemia due to VB6 deficiency is an important differential diagnosis to consider in cases with sideroblastic anemia associated with myelodysplastic syndrome (MDS). However, VB6 screening is underutilized in Japan as it is not covered by the national health insurance system, potentially leading to low screening rates. Methods This study retrospectively evaluated the relationships between VB6 (pyridoxal (PAL)) and other clinical parameters, including anemia, with univariate and multivariate regression analysis. Among 43 patients, we excluded one case where vitamin B6 supplementation had already started before blood sampling. We enrolled 42 patients who had undergone measurement of VB6 level (PAL) at Toho University Sakura Medical Center (Sakura, JPN) between September 2010 and October 2023. Results The PAL levels were significantly correlated with mean corpuscular volume (MCV) and mean corpuscular hemoglobin (MCH). Mean corpuscular hemoglobin concentration (MCHC) and vitamin B12 (VB12) also tended to correlate positively with PAL; however, no correlation was observed between PAL levels and other parameters. The PAL was positively correlated only with MCV and MCH in the subgroup analysis of hematological disorders alone. Only alkaline phosphatase (ALP) showed a significant decrease in the PAL <6 ng/mL group compared with the PAL ≥6 ng/mL groups; no significant differences were observed in RBCs, hemoglobin (Hgb), MCV, MCH, or MCHC between the PAL <6 and ≥6 ng/mL groups in both the overall cohort of 42 patients and the subset of 12 patients with hematological disease. Multivariate regression analysis revealed that only RBC and MCV levels independently and significantly affected Hgb levels. Conclusions These findings suggest that anemia due to VB6 deficiency may not always present as microcytic hypochromic anemia. Thus, VB6 deficiency must be included in the differential diagnosis of anemia, especially when there's suspicion for MDS.
目的 维生素B6(VB6)缺乏会导致出现环形铁粒幼细胞的小细胞低色素性贫血。因VB6缺乏所致的铁粒幼细胞性贫血是骨髓增生异常综合征(MDS)相关铁粒幼细胞性贫血病例中需要考虑的重要鉴别诊断。然而,在日本,VB6筛查未得到充分利用,因为它不在国家医疗保险体系覆盖范围内,这可能导致筛查率较低。方法 本研究采用单因素和多因素回归分析,回顾性评估VB6(吡哆醛(PAL))与包括贫血在内的其他临床参数之间的关系。在43例患者中,我们排除了1例在采血前已开始补充维生素B6的病例。我们纳入了2010年9月至2023年10月期间在东邦大学樱花医疗中心(日本樱花)接受VB6水平(PAL)测量的42例患者。结果 PAL水平与平均红细胞体积(MCV)和平均红细胞血红蛋白含量(MCH)显著相关。平均红细胞血红蛋白浓度(MCHC)和维生素B12(VB12)也倾向于与PAL呈正相关;然而,未观察到PAL水平与其他参数之间存在相关性。在仅血液系统疾病的亚组分析中,PAL仅与MCV和MCH呈正相关。与PAL≥6 ng/mL组相比,PAL<6 ng/mL组仅碱性磷酸酶(ALP)显著降低;在42例患者的总体队列以及12例血液系统疾病患者亚组中,PAL<6和≥6 ng/mL组之间的红细胞(RBC)、血红蛋白(Hgb)、MCV、MCH或MCHC均未观察到显著差异。多因素回归分析显示,只有RBC和MCV水平独立且显著影响Hgb水平。结论 这些发现表明,因VB6缺乏所致的贫血可能并不总是表现为小细胞低色素性贫血。因此,VB6缺乏必须纳入贫血的鉴别诊断中,尤其是在怀疑患有MDS时。